Biotech Values

[justrpaul]

The conference call was exceptionally brief, both the introductory remarks and the questions. I think the message from the brevity of the cc is - We have something powerful to tell you next week at AASLD, please wait till then.

I don't read anything into VX-500, other than they indicated that thew want to build a HCV franchise and to do so they are investing in a 2nd generation.